title: Commentary on "The effectiveness of varenicline medication guide for conveying safety information to patients: a REMS assessment survey" by Enger et al.
authors: US Food and Drug Administration, Silver Spring, MD, USA.
authors: Gerald J
authors: GJ
authors: Dal Pan
mesh_terms: D001552:Benzazepines / Q000009:adverse effects*; D004348:Drug Labeling; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008297:Male; D018722:Nicotinic Agonists / Q000009:adverse effects*; D010353:Patient Education as Topic; D011810:Quinoxalines / Q000009:adverse effects*; D012308:Risk Management; D016540:Smoking Cessation / Q000379:methods*; D000068580:Varenicline
chemical_list: D001552:Benzazepines; D018722:Nicotinic Agonists; D011810:Quinoxalines; D000068580:Varenicline